ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,258Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 340

$2.24M Total Retail Price of All Prescriptions

Rank: 1 out of 340

684 Patients Receiving at Least One Drug in Part D
28% Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Wisconsin
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

7% of this provider’s 684 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

N/A

Brand Name Drugs*

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 18%.

Prescription Price

$130 was the average price of a prescription from this provider, compared to $112 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
ALPRAZOLAM 981 177 113 B 1 12
ZIPRASIDONE HCL 840 132 110 A 10 2 22
ZOLPIDEM TARTRATE 822 159 116 3 15
ABILIFY 774 108 92 A 4 7
CLONAZEPAM 752 180 90 B 5 1
QUETIAPINE FUMARATE 706 118 89 A 6 2
LORAZEPAM 636 123 97 B 7 3
RISPERIDONE 573 186 71 A 8 4
SERTRALINE HCL 572 131 90 9 6
TRAZODONE HCL 559 122 92 10 5
MIRTAZAPINE 555 117 81 11 19
TEMAZEPAM 408 33 64 B 12 34
LAMOTRIGINE 397 101 52 13 8
DIVALPROEX SODIUM ER 392 87 68 14 20
DIAZEPAM 381 56 55 B 15 29
BUSPIRONE HCL 370 80 54 16 24
OLANZAPINE 343 65 40 A 17 9
ESCITALOPRAM OXALATE 338 90 52 18 23
BENZTROPINE MESYLATE 329 65 41 R 19 11
LYRICA 327 24 42 20 73
VENLAFAXINE HCL ER 309 78 50 21 13
PAROXETINE HCL 300 50 30 22 25
GABAPENTIN 297 19 36 23 31
PRISTIQ ER 296 67 35 24 52
ZONISAMIDE 252 42 40 25 79
BUPROPION XL 240 32 35 26 21
FLUOXETINE HCL 228 33 27 27 10
NAMENDA 174 130 16 28 38
DIVALPROEX SODIUM 170 67 33 29 27
HALOPERIDOL 151 72 13 A 30 28
SAVELLA 147 17 22 31 100
BUPROPION HCL SR 147 13 17 31 26
CYMBALTA 143 <11 19 33 17
AMPHETAMINE SALT COMBO 137 12 20 S2 34 30
DONEPEZIL HCL 134 88 15 35 46
TOPIRAMATE 132 0 20 36 33
LITHIUM CARBONATE 127 26 14 37 18
CARBAMAZEPINE 123 23 15 38 41
OXCARBAZEPINE 122 16 30 39 51
AMANTADINE 120 14 18 40 71
SAPHRIS 105 34 14 A 41 66
LATUDA 95 0 25 A 42 45
SEROQUEL XR 85 <11 <11 A 43 44
THIOTHIXENE 81 <11 <11 A 44 48
CLOZAPINE 78 <11 <11 A 45 16
VIIBRYD 77 15 15 46 67
CITALOPRAM HBR 66 <11 <11 47 14
FLUVOXAMINE MALEATE 66 <11 <11 47 55
BACLOFEN 63 <11 <11 49 101
LUNESTA 62 <11 <11 50 64
DOXEPIN HCL 58 11 12 51 61
OLANZAPINE ODT 52 <11 <11 A 52 56
CYCLOBENZAPRINE HCL 51 <11 <11 R 53 115
METHYLPHENIDATE HCL 50 <11 <11 S2 54 43
DEXTROAMPHETAMINE-AMPHETAMINE 50 <11 <11 S2 54 42
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 18, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.